Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 20INDUSTRY 7OTHER_GOV 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia 14Lymphoma, Large B-Cell, Diffuse 13Prostatic Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Multiple Myeloma 7Lymphoma, Large-Cell, Anaplastic 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasms, Plasma Cell 4Dendritic Cell Sarcoma, Interdigitating 4Waldenstrom Macroglobulinemia 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Lymphocytic, Chronic, B-Cell 3Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Immunoblastic Lymphadenopathy 2Cardiotoxicity 2Thymoma 1Thrombocytopenia 1Sezary Syndrome 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Pain 1Neutropenia 1

Interventions

romidepsin 1imetelstat 1Vincristine 1Prednisone 1Polymerase Chain Reaction 1Gemcitabine 1Doxorubicin 1Dexamethasone 1Cytogenetic Analysis 1Cyclophosphamide 1Cisplatin 1Chromosome Mapping 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, T-Cell, Peripheral × Prednisone × Clear all
NCT00217425 2023-06-18

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Eastern Cooperative Oncology Group

Phase 2 Completed
46 enrolled 7 charts
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡